Clinical Trial Update: Vitamin D and Curcumin Piperine Attenuates Disease Activity and Cytokine Levels in Systemic Lupus Erythematosus Patients [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating vitamin D and curcumin piperine for reducing disease activity and cytokine levels in systemic lupus erythematosus.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Systemic Lupus Erythematosus

Drugs mentioned

• Curcumin Piperine (curcumin)
• Vitamin D (Cholecalciferol)

Snippet

Sponsor: Saiful Anwar Hospital | Conditions: Systemic Lupus Erythematosus | Phase 2 | Status: COMPLETED